TRU-SENTIMENT ยท DeltaNeutral
BDX Trading Analysis - 11/06/2026 01:37 PM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
BDX (Becton Dickinson and Co.) at $212.84. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $707,330 vs put $3,600. RSI 80.0.
- Symbol
- BDX
- Price
- $212.84
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-11-06 13:37:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)Options flow (2026-11-06) methodology: Delta 40-60 only. Call dollar volume $707,330.00 (99.5%), put $3,600.00 (0.5%), total $710,930.00. Contracts: 520 calls / 5 puts; trades 6/1. Sentiment: Bullish. Filter ratio 1.3% (7 of 534 analyzed).
Conviction: Near-100% call dollar share shows strong directional bullish positioning. Embedded spread recommendation noted divergence: "Options sentiment is Bullish but technicals show no clear direction" (actually technicals are trending up but RSI extreme). Pure flow suggests near-term upside expectation, but spread engine advised wait for alignment.
Key Statistics: BDX
Fundamental Snapshot
Valuation
| P/E (trailing) | 63.00 |
| EPS (trailing 12 mo) | $3.32 |
| Market cap | $57.93B |
| Shares outstanding | 272.4M |
Dividend
| Dividend yield | 2.01% |
| Annual dividend | $4.20 |
| Ex-dividend date | 2026-09-09 |
Risk & range
| Beta | -0.17 |
| 52-week low | $140.11 |
| 52-week high | $214.78 |
| Historical volatility | 25.6% |
Ownership & trading
| Institutional ownership | 70.7% |
| Average daily volume | 1.8M sh |
Reported figures; no analyst estimates.
๐ Analysis
News Headlines & Context
The following items are based on general knowledge and are separated from the data-driven analysis below.
- Becton Dickinson (BDX) reported fiscal Q4 2026 results in early November, showing steady procedure volumes in its Medical segment and improved supply-chain efficiency.
- BDX announced a $4.20 annual dividend (ex-dividend Sept 9, 2026), maintaining its defensive income profile amid healthcare sector rotation.
- Recent FDA clearances for BDX infusion and diagnostic platforms were highlighted as catalysts for medium-term revenue stability.
- Macro headlines around declining hospital capital spending have posed a mild headwind to med-tech peers, though BDX's negative beta (-0.17) suggests low correlation to broad market swings.
- Context: Strong recent price action and bullish options flow (per embedded data) align with post-earnings optimism, but elevated RSI warns of short-term exhaustion.
Fundamental Analysis
Based strictly on the provided FUNDAMENTALS data:
- Trailing P/E is 63.00 with trailing EPS of $3.32; forward P/E, PEG, and price/book are null (not available).
- Market cap is $57,927,181,355.00 with 272,387,000 shares outstanding and average volume of 1,845,000.
- Dividend yield is 2.01% with rate of $4.20; ex-dividend date was 2026-09-09.
- Beta is -0.17 (inverse to market), 52-week range $140.11 to $214.78, institutional ownership 70.71%.
- Historical volatility is 25.65%; fiscal year end 2026-09-01.
- Missing fields: revenue growth, margins, ROE, debt/equity, FCF, analyst target, recommendation key (all null).
- Valuation appears rich on trailing P/E (63.00) vs typical med-tech peers; negative beta and 70.71% institutional hold suggest defensive positioning. Fundamentals are limited but show stable income and low market correlation, diverging from the sharp technical rally to 52-week highs.
Current Market Position
Current price per indicators is $212.72 (2026-11-05 close $212.72 from daily; minute bars show 2026-11-06 13:05 last close $212.85). Recent daily action: 2026-11-04 close $208.99 on volume 3,469,541; 2026-11-05 high $214.78, low $206.50, close $212.72 on volume 2,827,317 (above 20-day avg 1,135,855).
Minute bars (2026-11-05 09:30 to 2026-11-06 13:05, 122 bars): opened 2026-11-05 at $208.00, peaked $214.78 on 2026-11-05, drifted to $212.85 by 2026-11-06 13:05 with declining volume (last bar 7,717 vs early 150,970). Intraday momentum faded from strong opening rally to consolidation near $212.73โ$213.62.
Technical Analysis
Technical Indicators
SMAs aligned bullish: 5 > 20 > 50 ($203.06 > $195.43 > $187.58), no bearish cross. RSI 80.04 indicates overbought momentum. MACD 5.39 above signal 4.31, hist +1.08 bullish. Price above BB upper ($208.82) shows expansion; 30d range high $214.78 is current ceiling, low $175.71 far below. Price at 100% of 30d range high.
True Sentiment Analysis (Delta 40-60 Options)
Options flow (2026-11-06) methodology: Delta 40-60 only. Call dollar volume $707,330.00 (99.5%), put $3,600.00 (0.5%), total $710,930.00. Contracts: 520 calls / 5 puts; trades 6/1. Sentiment: Bullish. Filter ratio 1.3% (7 of 534 analyzed).
Conviction: Near-100% call dollar share shows strong directional bullish positioning. Embedded spread recommendation noted divergence: "Options sentiment is Bullish but technicals show no clear direction" (actually technicals are trending up but RSI extreme). Pure flow suggests near-term upside expectation, but spread engine advised wait for alignment.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.